If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDauch Corp Regulatory News (DCH)

Share Price Information for Dauch Corp (DCH)

Share Price is delayed by 15 minutes
Get Live Data
390.00    -8.00 (-2.01%)
Bid:
368.00
Ask:
394.00
Spread: 26.00 (7.065%)
Market Cap: £925.73m
DCH Live PriceLast checked at - London Stock Exchange

Intraday Dauch Corp Share Chart

Completion of Listing

4 Feb 2026 08:05

RNS Number : 6025R
Dauch Corporation
04 February 2026
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

4 February 2026

DAUCH CORPORATION COMPLETION OF LISTING

Further to Dauch Corporation's ("Dauch") announcement on 30 January 2026 in connection with the FCA's approval of and the publication of a prospectus in relation to Admission (the "Prospectus"), Dauch is pleased to announce that all of the issued Company Shares (including the New Company Shares), consisting of 235,668,048 shares of common stock with a par value of $0.01 each, have been admitted to the equity shares (international commercial companies secondary listing) category of the Official List of the FCA and to trading on the main market of the London Stock Exchange under the ticker "DCH", effective from 8:00 a.m. (UK time) today.

Further, it is expected that the New Company Shares, consisting of 116,971,627 shares of common stock with a par value of $0.01 each, will also be admitted to the New York Stock Exchange under the ticker "AXL" with effect from 9:30 a.m. (New York City time) today. The New York Stock Exchange ticker will change to "DCH" on 5 February, 2026.

Capitalised terms used in this announcement, unless otherwise defined, have the meanings given to them in the Prospectus.

Enquiries

Dauch

David H. Lim, Head of Investor Relations

+1 (313) 758-2006

Christopher M. Son, Vice President, Marketing & Communications

+1 (313) 758-4814

J.P. Morgan (Exclusive financial adviser to Dauch)

Ian MacAllister / Michael Murphy

+1 (212) 270 6000

Robert Constant / Jonty Edwards

+44 (0) 203 493 8000

FGS Global (PR adviser to Dauch)

Charlie Chichester / Rory King

+44 20 7251 3801

Allen Overy Shearman Sterling LLP is acting as legal adviser to Dauch.

Forward Looking Statements

This announcement includes forward-looking statements, which are based on current expectations and projections about future events. These statements may include, without limitation, any statements preceded by, followed by or including words such as "target", "believe", "expect", "aim", "intend", "may", "anticipate", "estimate", "plan", "project", "will", "can have", "likely", "should", "would", "could" and other words and terms of similar meaning or the negative thereof. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's and/or the Combined Group's business, results of operations, financial position, prospectus, growth, strategies and the industry in which it operates. Given these risks, uncertainties and assumptions, you are cautioned not to place undue reliance on such forward-looking statements. Save as required by law or by the UK Listing Rules of the FCA, each of the Company, Dowlais and J.P Morgan and their respective affiliates expressly disclaims any obligation or undertaking to update, review or revise any forward looking statement contained in this announcement whether as a result of new information, future developments or otherwise. Forward-looking statements speak only as of the date they are made.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUMWPUPQPUW
Date   Source Headline
15th Jun 20261:02 pmRNSUpdate on UAW Local 2093 Contract Ratification
1st Jun 20263:45 pmRNSUpdate Regarding Labor Contract Negotiations
1st Jun 20267:00 amRNSDauch to Present at UBS Auto Conference on June 3
12th May 20267:00 amRNSAwards of PSUs and RSUs PDMR Dealing
8th May 20266:11 pmRNSDauch Corporation Announces Filing of Form 10-Q
8th May 20264:18 pmRNSDauch Corporation Appoints New General Counsel
8th May 20261:00 pmRNSDauch Reports First Quarter 2026 Financial Results
5th May 202612:15 pmRNSAmended Result of AGM
5th May 20267:00 amRNSResult of AGM
20th Apr 20261:53 pmRNSPublication of Historical Pro Forma Financials
20th Apr 20261:05 pmRNSDeparture of Directors or Certain Officers
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
19th Mar 20263:04 pmRNSNotice of AGM, Proxy, and 2025 Annual Report
13th Feb 20261:00 pmRNSFinal Results
4th Feb 20263:20 pmRNSForm 8.3 - Dauch Corporation
4th Feb 20262:55 pmRNSForm 8.3 - Dauch Corporation
4th Feb 20262:20 pmRNSForm 8.3 - Dauch Corporation
4th Feb 20261:53 pmRNSForm 8.3 - DAUCH CORPORATION
4th Feb 20261:53 pmRNSForm 8.3 - DAUCH CORPORATION
4th Feb 202611:54 amRNSForm 8.5 EPT/Non RI DAUCH CORPORATION
4th Feb 202611:47 amRNSForm 8.5 (EPT/NON-RI)-Dauch Corporation
4th Feb 202611:34 amRNSForm 8.3 - Dauch Corporation
4th Feb 202610:54 amRNSForm 8.3
4th Feb 20268:05 amRNSCompletion of Listing
4th Feb 20268:00 amRNSDe-listing and Cancellation of Trading of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.